Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells

By sjmartinez • January 10, 2025

Wu K, Ge XX, Duan XF, Li JQ, Wang K, Chen QH, Huang ZM, Zhang WY, Wu Y, Li Q. Wip1 phosphatase activator QGC-8-52 specifically sensitizes p53-negative cancer cells to chemotherapy while protecting normal cells. Drug Resist Updat. 2024 Dec 24;79:101196. doi: 10.1016/j.drup.2024.101196. Epub ahead of print. PMID: 39787991.

Tags: breast cancer, Dephosphorylation, FOXO3a, General Internal Medicine, King Drew Med Ctr, Post Doc, Publications, TRAIL, Wip1

Bridging gaps throughout a patient’s journey with melanoma: a systematic review

Amarsi A, Xu J, Chan J, Jiang YC, Omar AZ, Meghdadi Y, Doshi A, Xie A, Wu A. Bridging gaps throughout a patient's journey with[...]

Cosmetic Laser Procedures and Nonsurgical Body Contouring in Patients With Skin of Color

Sheppard TK, Quiñonez RL, Burgess CM, Taylor SC, Agbai ON. Cosmetic Laser Procedures and Nonsurgical Body Contouring in Patients With Skin of Color. Cutis. 2025[...]

Sustained Effectiveness of a 211 Call Center With Early Childhood Care Coordination

Nelson BB, Dudovitz RN, Romley JA, Thompson LR, Vangala S, Gallegos A, Gulsrud A, Calderon K, Porras-Javier L, Herrera P, Aceves I, Baker CN, Chung[...]